Yaniv Erlich
Co-Founder and CEO
Undecimal Bio
AI-driven siRNA delivery to take RNA therapeutics beyond the liver
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Undecimal Bio pairs large-scale combinatorial chemistry with transformer-based AI to discover small-molecule conjugates that deliver siRNA into tissues beyond the liver. Its screens score productive intracellular delivery and feed models that map structure-activity relationships across tissues; first programs target renovascular disease in the kidney and vascular system. Co-founders include CEO Prof. Yaniv Erlich and COO Shaul Ilan. In October 2026 the company launched publicly with $18 million in financing reported by Endpoints News.
- Website
- undecimalbio.com
- Location
- Cambridge, UK
- Added via
- web
- Ownership
- unclaimed
Where to go
Social profiles
Links
Founders
Shaul Ilan
Co-Founder and COO